InsiderClue
Stocks · Health care · Pharmaceutical Preparations

GENELUX Corp

GNLX Clue Score27
United States Fiscal year ends December CIK 0001231457 Results filed 25 Mar 2025
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Lourie S. Zak
29 May 2024
Chief Financial Officer
Buy
31,250
—
no price
Sean Ryder
29 May 2024
General Counsel
Buy
10,000
—
no price
Ralph Smalling
29 May 2024
Head of Regulatory
Buy
1,250
—
no price
Thomas Zindrick
29 May 2024
President and CEO
Buy indirect
200,000
—
no price
Yong Yu
29 May 2024
VP, Clinical Trial Operations
Buy
2,500
—
no price
Mary Mirabelli
29 May 2024
Director
Buy
8,000
—
no price
John Thomas
29 May 2024
Director
Buy
2,500
—
no price
John W Smither
29 May 2024
Director
Buy
6,250
—
no price
James L Tyree
29 May 2024
Director
Buy
6,250
—
no price
Qian Zhang
26 Jan 2023
Associate VP, Research
Buy indirect
200
$6.25
$1.25K
Show all 152 transactions →

What was left out

Form 4 filings counted 166
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 10
Sales at will 128
Transactions with no price 9
Shares from compensation/vesting 4,605,497
History held since 30 Jan 2023